In the present study, we evaluated the effects of CB2 stimulation, with a selective agonist (JWH-133), and those of Dexa on ITP-MSC survival and immunosuppressive capacity. The gene discussed is CNR2; the disease is autoimmune thrombocytopenic purpura.